The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 08, 2017
Filed:
Aug. 29, 2014
Applicant:
Ambit Biosciences Corporation, San Diego, CA (US);
Inventors:
Mark W. Holladay, San Diego, CA (US);
Gang Liu, San Diego, CA (US);
Martin W. Rowbottom, San Diego, CA (US);
Assignee:
Ambit Biosciences Corporation, San Diego, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 498/08 (2006.01); A61K 31/4365 (2006.01); A61K 31/437 (2006.01); A61K 31/4375 (2006.01); A61K 31/47 (2006.01); A61K 31/498 (2006.01); A61K 31/4985 (2006.01); A61K 31/5377 (2006.01); A61K 31/5386 (2006.01); A61K 31/655 (2006.01); A61K 45/06 (2006.01); C07D 413/12 (2006.01); C07D 471/04 (2006.01); C07D 487/04 (2006.01); C07D 495/04 (2006.01); C07D 403/12 (2006.01); C07D 413/14 (2006.01); C07D 498/14 (2006.01);
U.S. Cl.
CPC ...
C07D 498/08 (2013.01); A61K 31/437 (2013.01); A61K 31/4365 (2013.01); A61K 31/4375 (2013.01); A61K 31/47 (2013.01); A61K 31/498 (2013.01); A61K 31/4985 (2013.01); A61K 31/5377 (2013.01); A61K 31/5386 (2013.01); A61K 31/655 (2013.01); A61K 45/06 (2013.01); C07D 403/12 (2013.01); C07D 413/12 (2013.01); C07D 413/14 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01); C07D 495/04 (2013.01); C07D 498/14 (2013.01);
Abstract
Biaryl acetamide compounds and compositions and their methods of use are provided for modulating the activity of class III receptor tyrosine kinases and for the treatment, prevention or amelioration of one or more symptoms of disease of disorder mediated by class III receptor tyrosine kinases.